Navigation Links
McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products
Date:7/28/2011

; and ZYRTEC-D®12-HOUR®.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of McNEIL-PPC, Inc. and/or Johnson & Johnson.  Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; trends toward health care cost containment; and increased scrutiny of the healthcare industry by government agencies.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 2, 2011.  Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.  Neither McNEIL-PPC, Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)

*The third-party trademarks used herein are registered trademarks of their respective owners and not McNEIL-PPC, Inc.

CONSUMER INQUIRIES:
1-877-414-7711


'/>"/>
SOURCE McNeil Consumer Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
2. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
3. McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP
4. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
5. McNeil Consumer Healthcare Announces a Voluntary Nationwide Recall of All Lots of TYLENOL(R) Arthritis Pain 100 Count With EZ-OPEN CAP
6. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
7. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
8. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
9. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
10. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
11. McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014  Serco Inc., a provider ... Company has been awarded a re-compete contract to ... and its Deployable Medical Systems.  Serco will provide ... to provide world-class healthcare to meet warfighter and ... the globe. The five year contract has a ...
(Date:7/28/2014)... 2014  Air Products (NYSE: APD ) ... is vital to any healthcare facility. This understanding has ... improve the efficiency of its oxygen supply systems, but ... systems—including systems for emergency oxygen supply and ... at the 51 st ASHE Annual Conference ...
(Date:7/28/2014)...  VigeneTech, Inc, in collaboration with BioLegend, Inc., ... Software, an OEM software solution for analysis of ... offers varieties of bead-based multi-analyte immunoassay products for ... VigeneTech,s data analysis software, FCS data files can ... LEGENDplex™ software is a robust ...
Breaking Medicine Technology:Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... Hypertension demonstrate that early blockade of angiotensin II reversed vascular ... ... June 16 A new study published in the,current Journal of ... was effective in reversing,the narrowing of the arteries that occurs in ...
... 90th Annual Meeting -, SAN FRANCISCO and ... BNVI ) today announced results from in vitro ... data were presented at the,Endocrine Society 90th Annual ... stem cells and expressing native estrogen,receptors, MF101, an ...
Cached Medicine Technology:New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 2New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 3New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 5New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 6New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 7New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 8New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 9Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation 2Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation 3
(Date:7/28/2014)... The report “Industrial Enzymes Market by Types ... Agents, Bio-Fuel, Animal Feed), & Geography - Global ... the global industrial enzymes market with analysis and ... It also identifies driving and restraining factors for ... trends, opportunities, burning issues, winning imperatives, and challenges. ...
(Date:7/28/2014)... (Boston)-- Researchers from Boston University School of Medicine (BUSM) ... increase the risk of developing Alzheimer,s disease (AD). The ... new drug treatment options that target PLXNA4 specifically. These ... , AD is the most frequent age-related dementia affecting ... 65 and older, and more than 40 percent of ...
(Date:7/28/2014)... "Fist bumping" transmits significantly fewer bacteria than ... cultural expectation of hand-to-hand contact between patients and ... August issue of the American Journal of ... Association for Professionals in Infection Control and Epidemiology ... of Biological, Environmental, and Rural Sciences at Aberystwyth ...
(Date:7/28/2014)... 2014) -- Researchers from The University of Texas Health Science ... institutions have identified a combination of pills that cures 9 ... drugs sofosbuvir and simeprevir, with or without ribavirin, cured 93 ... by patients, according to the study published today in ... the U.S. , Eric Lawitz, M.D., clinical professor in ...
(Date:7/28/2014)... WA (PRWEB) July 28, 2014 ... consulting and care management organizations, has published a ... low-cost approach to engaging patients and families in ... environments at multiple hospitals, the toolkit provides a ... huddle” with patients and their families early in ...
Breaking Medicine News(10 mins):Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:Researchers identify potential biomarker for AD 2Health News:Fist-bumping beats germ-spreading handshake, study reports 2Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:Patient Engagement in Hospital Infection Control: Online Toolkit Provides a New Solution 2
... help college students retain and integrate new information to ... abstract that will be presented Tuesday, June 14, in ... of the Associated Professional Sleep Societies LLC (APSS). ... microeconomics test was preserved after a 12-hour period that ...
... Getting six to nine hours of sleep per night is ... ratings for depression, suggests a research abstract that will be ... the 25th Anniversary Meeting of the Associated Professional Sleep Societies ... sleep duration of six to nine hours per night had ...
... , MONDAY, June 13 (HealthDay News) -- Spending ... increased overall and especially among certain groups of patients, a ... aged 18 and older who used glaucoma medication between 2001 ... medications increased from $445 in 2001 to $557 in 2006. ...
... Ill. June 13, 2011 A new ... preparation are associated with relatively high adenoma (precancerous ... substantially decreases colonoscopy effectiveness and may mandate an ... context of suboptimal bowel preparation, of all adenomas ...
... National Institutes of Health researchers have identified a new pathway ... The study provides insights about the interaction between a toxic ... chromosomes like aglets, the plastic tips that bind the ends ... National Human Genome Research Institute (NHGRI) appears in the June ...
... China? Boys are considered a greater asset for farming, but ... want a boy at any cost doubled? Sociologist ... families in China choose to abort girls. When ... born in China, a nationwide campaign was started against sex-selective ...
Cached Medicine News:Health News:Sleep can boost classroom performance of college students 2Health News:The good life: Good sleepers have better quality of life and less depression 2Health News:Polyp miss rates high for colonoscopies done after poor bowel preparation 2Health News:Polyp miss rates high for colonoscopies done after poor bowel preparation 3Health News:Polyp miss rates high for colonoscopies done after poor bowel preparation 4Health News:NIH researchers find new clues about aging 2Health News:NIH researchers find new clues about aging 3Health News:NIH researchers find new clues about aging 4Health News:Has China's campaign against female feticide done more harm than good? 2
... is a threaded titanium anchor, ... procedures. The anchor features wide ... to optimize bone purchase, as ... to prevent suture binding. Fastin ...
... 5mm Super Revo Suture Anchor offers a ... a mini-open rotator cuff repair. The cutting ... is pre-threaded with two #2 strands of ... suture management are avoided with the Independent ...
... 5mm Super Revo Suture Anchor offers a ... a mini-open rotator cuff repair. The cutting ... is pre-threaded with two #2 strands of ... suture management are avoided with the Independent ...
The Linvatec UltraFix Suture Anchor System's smooth surface until deployed eliminates tissue, bone and suture damage and its ultra smooth eyelet hole preserves suture integrity....
Medicine Products: